Meta Pixel

News and Announcements

Unlocking Investor Trust: Anticipate Questions and Build Trust with FAQs

  • Published May 16, 2023 11:00PM UTC
  • Publisher Wholesale Investor
  • Categories Capital Raising Tips

As a startup founder raising capital, it’s essential to make the investment process as straightforward as possible for your potential investors. In this video, you will learn that one way to demonstrate a professional approach is to anticipate and answer potential investors’ questions before they ask them.

By providing frequently asked questions (FAQs) on your website or in your investment materials, you can give investors the information they need to make an informed decision about investing in your company. This not only helps build trust and credibility but can also save time during the due diligence process, as investors will already have answers to many of their questions.

Here, we provide several examples of common investor questions and suggest how founders can address them in their FAQs. From inquiries about the size of the market to questions about the company’s management team, the FAQs can cover a wide range of topics. It is recommended to update the FAQs regularly to reflect changes in the business or in response to feedback from investors.

YouTube player

Overall, it is essential to be proactive in addressing investors’ questions and providing clear and concise information to help potential investors make informed decisions. By anticipating and answering common questions through a well-crafted FAQ, startup founders can demonstrate their professionalism and improve their chances of successfully raising capital.

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now